DermTech DMTK
$ 0.09
-11.32%
Annual report 2023
added 02-29-2024
Country |
USA |
IPO year |
2017 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITALSPB |
CEO |
Dr. John D. Dobak |
Employees in the company |
60 |
Shares |
32.6 M |
Market Cap[1] |
$ 2.94 M |
EBITDA (LTM) |
$ -120 M |
P/E (LTM) |
-0.4 |
P/S (LTM) |
2.81 |
EPS (LTM) |
-3.54 |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.